Esophageal Diseases Clinical Trials

13 recruiting

Esophageal Diseases Trials at a Glance

13 actively recruiting trials for esophageal diseases are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Hyderabad, Cairo, and Cleveland. Lead sponsors running esophageal diseases studies include Asian Institute of Gastroenterology, India, CDx Diagnostics, and Bács-Kiskun County Teaching Hospital.

Browse esophageal diseases trials by phase

Treatments under study

About Esophageal Diseases Clinical Trials

Looking for clinical trials for Esophageal Diseases? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Esophageal Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Esophageal Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis+9 more
Seattle Children's Hospital200 enrolled1 locationNCT06315179
Recruiting

Esophageal Cancer Risk Registry

Esophageal CancerEsophageal DiseasesEsophageal Achalasia+2 more
University of Pittsburgh7,000 enrolled1 locationNCT00260585
Recruiting

PRospective Registry of Esophageal Motility

Esophageal Diseases
IRCCS San Raffaele10,000 enrolled1 locationNCT07506746
Recruiting

Clinical Utility of WATS3D: A 5-Year Prospective Study

Barrett EsophagusEsophageal DiseasesGastro Esophageal Reflux+1 more
CDx Diagnostics90,000 enrolled1 locationNCT04312633
Recruiting
Phase 1

Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement

Esophageal Diseases
Harvard Apparatus Regenerative Technology, Inc.10 enrolled3 locationsNCT05877300
Recruiting
Phase 2Phase 3

Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy

EsophagectomyEsophageal Cancer SurgeryDelayed Gastric Emptying Following Procedure+4 more
The Cleveland Clinic170 enrolled1 locationNCT06721520
Recruiting

Esophageal and Gastric Diseases With Robotically Controlled Magnetic Capsule Endoscopy

Esophageal DiseasesVideo Capsule Endoscopy
Bács-Kiskun County Teaching Hospital300 enrolled1 locationNCT04068480
Recruiting
Not Applicable

Standard Versus Oesophago-gastric Junction Complex Myotomy for Treatment naïve Type 2 Achalasia Patients

Esophageal Diseases
Asian Institute of Gastroenterology, India158 enrolled1 locationNCT06870630
Recruiting
Not Applicable

Comparative Assessment of Esophagitis in Cases With and Without Esophageal Motility Disorders: A Prospective Study

Esophageal Diseases
Asian Institute of Gastroenterology, India200 enrolled1 locationNCT06835374
Recruiting
Not Applicable

Role of Topical Steroid Injection With Refractory Benign Esophageal Stricture Endoscopic Dilatation in Children

Esophageal DiseasesPediatric Disorder
Mohammad Daboos21 enrolled1 locationNCT06514079
Recruiting
Not Applicable

Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.

Head and Neck NeoplasmsEsophageal NeoplasmsNeoplasms+6 more
Taipei Veterans General Hospital, Taiwan20 enrolled1 locationNCT06365866
Recruiting
Phase 2

Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.

Esophageal NeoplasmsDigestive System NeoplasmsEsophageal Diseases
Fujian Cancer Hospital75 enrolled1 locationNCT05624099
Recruiting
Phase 2

Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients

Esophageal Squamous Cell CarcinomaEsophageal NeoplasmsNeoplasms by Site+8 more
Jiangxi Provincial Cancer Hospital30 enrolled1 locationNCT05252078